Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D G Efremov
The Use of Low-Dose Alemtuzumab in Pretreated B-Cell Chronic Lymphocytic Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Related publications
FDA Drug Approval Summary: Alemtuzumab as Single-Agent Treatment for B-Cell Chronic Lymphocytic Leukemia
Oncologist
Cancer Research
Medicine
Oncology
Cytotoxic Lymphocytes in B-Cell Chronic Lymphocytic Leukemia
Annals of Hematology
Medicine
Hematology
First-Line Treatment of Chronic Lymphocytic Leukemia: Role of Alemtuzumab
OncoTargets and Therapy
Oncology
Pharmacology
Targeting the B Cell Receptor Pathway in Chronic Lymphocytic Leukemia
Leukemia and Lymphoma
Cancer Research
Oncology
Hematology
Lack of Allelic Exclusion in B Cell Chronic Lymphocytic Leukemia
Journal of Experimental Medicine
Medicine
Allergy
Immunology
Filgrastim and Alemtuzumab (Campath-1h) for Refractory Chronic Lymphocytic Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Metformin Inhibits Cell Cycle Progression of B-Cell Chronic Lymphocytic Leukemia Cells
Oncotarget
Oncology
Cd160 Expression in B Chronic Lymphocytic Leukemia (B-Cll.).
International Journal of Advanced Research
ICOS Gene Polymorphisms in B-Cell Chronic Lymphocytic Leukemia in the Polish Population
Folia Histochemica et Cytobiologica
Medicine
Forensic Medicine
Pathology
Histology